B-Alive

B-Alive is a women's health biotech and medical device venture focused on treating urinary incontinence, overactive bladder, and related pelvic floor dysfunction. The company describes itself as a biotechnology and medical device division of BladderCell and is developing regenerative products that combine bioelectric stimulation with biologic compositions intended to restore bladder, urethral sphincter, muscle, nerve, and tissue function. Its disclosed product concepts include the B-Alive PelvicStim non-invasive stimulation device and a proprietary BC-15 regenerative composition containing stem cells, stromal fraction, exosomes, amniotic fluid, growth factors, microRNA gel, nanoparticles, hydrogel, Wharton's jelly, and bladder matrix. The company states that it has completed a 30-patient clinical study for its non-invasive bioelectric stimulation product, but publicly available information does not show a conventional drug-development pipeline with named clinical-stage assets. Overall, B-Alive appears to be an early-stage regenerative medicine and medtech company focused on female urology and pelvic health.